.
BioEnterprise

ReXceptor

ReXceptor is developing disease modifying small molecule therapeutics for the treatment of Alzheimer’s disease and other neurological disorders.

Funding

GLIDE Innovation Fund, BrightFocus Foundation, Alzheimer’s Drug Discovery Foundation, Case Western Reserve University, JumpStart

Stage

Preclinical